SEC Form 4 · accession 0001493152-18-001498
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J. O'Connor
Officer — CEO · Director
Period of report
Feb 5, 2018
Accepted (ET)
Feb 6, 2018 · 9:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2018 | P | 16,667 | $1.50 | A | 16,667 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares purchased were pursuant to a Confidentially Marketed Public Offering (CMPO)